文献速递细菌感染、耐药与抗菌药物

哥伦比亚碳青霉烯耐药肺炎克雷伯菌分离株基因组流行病学的复杂性亟需加强基于全基因组测序的监测项目

Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究对哥伦比亚国家参考实验室2013—2017年收集的425株碳青霉烯耐药肺炎克雷伯菌(CRKP)进行全基因组测序分析,发现91.5%为产碳青霉烯酶菌株,以CG258克隆群最常见(占48.39%),并首次在哥伦比亚报告高毒力CRKP克隆CG380。作者认为哥伦比亚CRKP流行病学复杂,强调基于全基因组测序的监测对追踪序列型、移动遗传元件及耐药与毒力基因演化趋势的重要性。

要点

  • 425株CRKP中91.5%为产碳青霉烯酶菌株,CG258最常见(48.39%)。
  • 检出blaKPC-3、blaKPC-2、blaNDM-1、blaNDM-9、blaVIM-2、blaVIM-4和blaVIM-24等碳青霉烯酶基因。
  • 高毒力CRKP克隆CG380为哥伦比亚首次报告。

核心结论

  • 研究勾勒出哥伦比亚复杂的CRKP流行病学:CG258克隆性扩张并携带特定移动遗传元件中的特定碳青霉烯酶,而其他高风险克隆(CG147、CG307和CG152)携带的碳青霉烯酶更为多样。
  • 哥伦比亚的具体情况强调基于全基因组测序的监测对监测序列型、移动遗传元件及耐药与毒力基因演化趋势的重要性。

研究设计与样本

  • 基于哥伦比亚国家参考实验室(Instituto Nacional de Salud,INS)2013—2017年样本收集,对来自21个部门的425株CRKP分离株进行HiSeq-X10®Illumina高通量测序。
  • 生物信息学分析主要使用英国国家健康研究所全球健康研究单位(GHRU)抗菌药物耐药基因组监测项目与AGROSAVIA合作开发的流程。

主要发现

  • 425株CRKP分离株中91.5%为产碳青霉烯酶菌株。
  • 数据支持CRKP在哥伦比亚近期扩张并呈地方性流行,存在7个高风险克隆的流行,最常见为CG258(占分离株的48.39%)。
  • 鉴定出编码碳青霉烯酶的基因blaKPC-3、blaKPC-2、blaNDM-1、blaNDM-9、blaVIM-2、blaVIM-4和blaVIM-24,以及多种移动遗传元件(MGE)。
  • CRKP分离株毒力低,但25.2%的分离株携带colibactin(clb3),并首次在哥伦比亚报告高毒力CRKP克隆(CG380)。
  • ST258、ST512和ST4851的核心基因组多样性低(ANI > 99.9%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging public health problem. This study explores the specifics of CRKP epidemiology in Colombia based on whole genome sequencing (WGS) of the National Reference Laboratory at Instituto Nacional de Salud (INS)'s 2013-2017 sample collection. METHODS: A total of 425 CRKP isolates from 21 departments were analyzed by HiSeq-X10®Illumina high-throughput sequencing. Bioinformatic analysis was performed, primarily using the pipelines developed collaboratively by the National Institute for Health Research Global Health Research Unit (GHRU) on Genomic Surveillance of Antimicrobial Resistance (AMR), and AGROSAVIA. RESULTS: Of the 425 CRKP isolates, 91.5% were carbapenemase-producing strains. The data support a recent expansion and the endemicity of CRKP in Colombia with the circulation of 7 high-risk clones, the most frequent being CG258 (48.39% of isolates). We identified genes encoding carbapenemases blaKPC-3, blaKPC-2, blaNDM-1, blaNDM-9, blaVIM-2, blaVIM-4, and blaVIM-24, and various mobile genetic elements (MGE). The virulence of CRKP isolates was low, but colibactin (clb3) was present in 25.2% of isolates, and a hypervirulent CRKP clone (CG380) was reported for the first time in Colombia. ST258, ST512, and ST4851 were characterized by low levels of diversity in the core genome (ANI > 99.9%). CONCLUSIONS: The study outlines complex CRKP epidemiology in Colombia. CG258 expanded clonally and carries specific carbapenemases in specific MGEs, while the other high-risk clones (CG147, CG307, and CG152) present a more diverse complement of carbapenemases. The specifics of the Colombian situation stress the importance of WGS-based surveillance to monitor evolutionary trends of sequence types (STs), MGE, and resistance and virulence genes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Saavedra SY, Bernal JF, Montilla-Escudero E, et al. Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs. Clin Infect Dis. 2021. PMID: 34850835. doi:10.1093/cid/ciab777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。